Pricing Log in Create free account

Allarity Therapeutics, Inc. (ALLR) vs Lipocine Inc. (LPCN)

Allarity Therapeutics, Inc. and Lipocine Inc. are both Biotechnology companies. Allarity Therapeutics, Inc. and Lipocine Inc. are of similar size ($13.9M and $13.2M). Allarity Therapeutics, Inc. has the higher net margin (0.00% vs −755.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Allarity Therapeutics, Inc. leads on 7 and Lipocine Inc. on 7.

Valuation

Metric ALLR LPCN Biotechnology median
P/E n/m n/m 8.50
P/S n/m 7.75 9.71
P/B 4.05 0.56 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.90 0.64 0.64
EV/Sales n/m (5.21) 9.21
Earnings yield (86.67%) (126.35%) (33.15%)
Free cash flow yield (98.32%) (92.84%) (25.50%)

Profitability

Metric ALLR LPCN Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (800.80%) 0.00%
Net margin 0.00% (755.11%) 0.00%
Free cash flow margin 0.00% (713.02%) 0.00%
Return on equity (157.09%) (60.94%) (56.36%)
Return on assets (46.26%) (55.89%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALLR LPCN Biotechnology median
Revenue growth (TTM) — (63.48%) 6.02%
EPS growth (last fiscal year) 95.02% (93,988.89%) 30.26%
Revenue growth, 5-year CAGR — 64.32% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALLR LPCN Biotechnology median
Debt to equity 0.40 0.00 0.00
Current ratio 1.11 11.48 4.72
Net debt to EBITDA 1.05 1.42 0.96

Dividend

Metric ALLR LPCN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ALLR LPCN Biotechnology median
Market cap 13.24m 13.85m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack